Web Images Videos Maps News Shopping Gmail more »
Sign in
Go to Blog Search Home

  
  Advanced Blog Search
  Preferences
 Blog resultsResults 1 - 10 of about 511 for actiq sales. (0.21 seconds) 
Browse Top Stories
Published
Anytime

Subscribe:
Blogs Alerts Blogs Alerts
Atom | RSS
Sorted by relevance    Sort by date
 
Judge Revisits Cephalon's Off-Label Madness: Actiq Is "an ER on a ...
2 Sep 2009 by Jim Edwards  
The timeline starts When Cephalon acquired Actiq from Anesta in 2000, and the drug had sales of just $15 million. Its FDA approval was “to be used only in the care of cancer patients,” the judge says. Because fentanyl is so addictive, ...
Pharma RSS Feed - http://industry.bnet.com/pharma/ - References
[ More results from Pharma RSS Feed ]

Alleged Off-Label Marketing at Cephalon Leads to Big Settlement ...
30 Sep 2008 by Dan Slater  
A two-year investigation by the Connecticut attorney general concluded last year that the drug maker engaged in questionable practices to expand sales of Actiq, approved only to treat cancer pain, by setting unrealistically high sales ...
WSJ.com: Law Blog - http://blogs.wsj.com/law/

Actiq Lawsuit Filed Over Tooth Decay from Fentanyl Lollipops ...
17 Sep 2009 by AboutLawsuits  
Although Actiq is only approved for the treatment of cancer pain in patients who have already grown tolerant to other opioids, Cephalon has been criticized for marketing the drug in a way that led to off-label sales. ...
AboutLawsuits.com - http://www.aboutlawsuits.com/
[ More results from AboutLawsuits.com ]

An update on activities in the firms Mass Torts section
16 Dec 2009 by Beasley Allen  
Actiq is a powerful opioid narcotic that is delivered to the bloodstream by a lollipop lozenge. Anesta, a Utah-based corporation, developed Actiq. The company was purchased by Cephalon in 2000. Actiq initially had sales in the tens of ...
Jere Beasley Report - http://www.jerebeasleyreport.com/
[ More results from Jere Beasley Report ]

Health Care Renewal: Cephalon's Promotion of Actiq
22 Nov 2006 by Roy M. Poses MD  
From setting unrealistically high sales quotas to pushing larger prescriptions at higher doses, drug maker Cephalon Inc. engaged in questionable practices to expand sales of Actiq, a powerful narcotic lollipop approved only to treat ...
Health Care Renewal - http://hcrenewal.blogspot.com/ - References
[ More results from Health Care Renewal ]

Healthcare Sales & Marketing Network News: Cephalon, Inc ...
1 Feb 2010 by Cephalon  
Mepha manufactures and markets over 120 products in 50 countries and recognized sales of approximately CHF 400 million in 2009. With its exposure to high-growth international markets, and a track record of innovation, Mepha has achieved compound annual growth .... FENTORA® (fentanyl buccal tablet) [C-II], TRISENOX® (arsenic trioxide) injection, GABITRIL® (tiagabine hydrochloride), PROVIGIL® (modafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. ...
HSMN NewsFeed - http://salesandmarketingnetwork.com/?q=Save+Us+From+Berlusconi - References
[ More results from HSMN NewsFeed ]

Actiq are for off-label use - Managed Care Matters
19 Feb 2007 by Joe Paduda  
As an indication of how prevalent off-label usage has become, analysis of data from the workers compensation industry indicate over $80 million of Actiq sales are for workers compensation patients, a figure that is nothing short of ...
Managed Care Matters - http://www.joepaduda.com/ - References
[ More results from Managed Care Matters ]

order actiq without prescription, buy cheap actiq online
10 Jul 2009
cheap actiq sales cheap actiq no script. actiq online overnight delivery cod. actiq with free dr consultation no prescription actiq fedex delivery. actiq fed ex cheap buy actiq with no rx cheap actiq without prescription ...
Local Activity for New York, NY - http://www.merchantcircle.com/directory/NY-New-York

Healthcare Sales & Marketing Network News: Barr Launches Generic ...
27 Sep 2006 by Barr Pharmaceuticals  
ACTIQ is indicated for the treatment of breakthrough cancer pain in opioid tolerant patients and has current annual sales of approximately $590 million, based on IMS sales data for the twelve months ended July 2006. ...
HSMN NewsFeed - http://salesandmarketingnetwork.com/news.php

מדיסון פארמה (מאיר יעקובסון): היתרונות של Actiq (מדיסון תרופות ) - [ Translate this page ]
14 Jan 2010 by מדיסון פארמה (מאיר יעקובס...  
היתרונות של Actiq (מדיסון תרופות ). מהי דרך הפעולה של Actiq, ההופכת אותה ליעילה ולמהירה כל כך? רבע מהמינון הכולל נספג במהלך 15 הדקות הראשונות דרך רירית הפה ומגיע ישירות לזרם הדם, וכך מגיע במהירות למערכות הגוף השונות. ... Meir Jakobsohn obtained a B.A. in Economics from Bar Ilan University and an Executive MBA from Bradford University (UK). He served as M. Jakobsohn Ltd's COO between 1991-1996. Meir's expertise lies in sales and the development of new business ventures. ...
מדיסון פארמה (מאיר יעקובס... - http://medisonltd.blogspot.com/
[ More results from מדיסון פארמה (מאיר יעקובס... ]

Stay up to date on these results:




 
  

Google Home - About Google Blog Search Beta - Information for Blog Authors

©2009 Google